Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brian J. Van Lenten
An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E-Null Mice
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Related publications
Acyl-CoA:Cholesterol Acyltransferase Inhibition Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
An Apolipoprotein A-I Mimetic Peptide Designed With a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice
PLoS ONE
Multidisciplinary
Increased Atherosclerosis and Smooth Muscle Cell Hypertrophy in Natriuretic Peptide Receptor a-/-Apolipoprotein E-/- Mice
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Apolipoprotein AI Transgene Corrects Apolipoprotein E Deficiency-Induced Atherosclerosis in Mice.
Journal of Clinical Investigation
Medicine
597. Therapy of Atherosclerosis in Apolipoprotein E-Deficient Mice
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Quantitative Trait Loci Affecting Atherosclerosis at the Aortic Root Identified in an Intercross Between DBA2J and 129S6 Apolipoprotein E-Null Mice
PLoS ONE
Multidisciplinary
Fibrinogen Deficiency Reduces Vascular Accumulation of Apolipoprotein(a) and Development of Atherosclerosis in Apolipoprotein(a) Transgenic Mice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The 18 kDa Translocator Protein and Atherosclerosis in Mice Lacking Apolipoprotein E
Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
Mediators of Inflammation
Immunology
Cell Biology
